SREBF1 and hypertriglyceridemia: Compared with injection of hydrogel-encapsulated T317, the oral administration or injection of free T317 stimulates expression of FASN and SREBP1, thereby inducing de novo fatty acid biosynthesis, fatty liver and hypertriglyceridemia.